Poor Trial Results May Prompt Maker to Pull ALS Drug Relyvrio From Market

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a...

Poor Trial Results May Prompt Maker to Pull ALS Drug Relyvrio From Market
MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow